First Foundation Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Sell |
9,520
-310
| -3% | -$68.8K | 0.08% | 140 |
|
|
2025
Q4 | $2.25M | Buy |
9,830
+34
| +0.3% | +$7.75K | 0.08% | 133 |
|
|
2025
Q3 | $2.27M | Sell |
9,796
-77
| -0.8% | -$15.7K | 0.08% | 137 |
|
|
2025
Q2 | $1.83M | Buy |
9,873
+1,632
| +20% | +$303K | 0.07% | 144 |
|
|
2025
Q1 | $1.73M | Sell |
8,241
-671
| -8% | -$130K | 0.07% | 136 |
|
|
2024
Q4 | $1.58M | Buy |
8,912
+13
| +0.1% | +$2.39K | 0.06% | 142 |
|
|
2024
Q3 | $1.76M | Sell |
8,899
-811
| -8% | -$151K | 0.07% | 134 |
|
|
2024
Q2 | $1.67M | Sell |
9,710
-156
| -2% | -$25.8K | 0.06% | 130 |
|
|
2024
Q1 | $1.8M | Buy |
9,866
+760
| +8% | +$131K | 0.07% | 126 |
|
|
2023
Q4 | $1.41M | Sell |
9,106
-5,952
| -40% | -$868K | 0.06% | 145 |
|
|
2023
Q3 | $2.24M | Buy |
15,058
+1,089
| +8% | +$160K | 0.1% | 119 |
|
|
2023
Q2 | $1.88M | Buy |
13,969
+943
| +7% | +$138K | 0.08% | 133 |
|
|
2023
Q1 | $2.08M | Buy |
13,026
+1,360
| +12% | +$208K | 0.1% | 126 |
|
|
2022
Q4 | $1.89M | Sell |
11,666
-138
| -1% | -$21.2K | 0.09% | 126 |
|
|
2022
Q3 | $1.58M | Buy |
11,804
+206
| +2% | +$29.6K | 0.08% | 137 |
|
|
2022
Q2 | $1.78M | Sell |
11,598
-1,708
| -13% | -$261K | 0.08% | 129 |
|
|
2022
Q1 | $2.16M | Buy |
13,306
+1,323
| +11% | +$192K | 0.08% | 127 |
|
|
2021
Q4 | $1.62M | Buy |
11,983
+376
| +3% | +$44.4K | 0.06% | 162 |
|
|
2021
Q3 | $1.25M | Buy |
11,607
+513
| +5% | +$58.6K | 0.05% | 177 |
|
|
2021
Q2 | $1.25M | Buy |
11,094
+1,268
| +13% | +$143K | 0.05% | 191 |
|
|
2021
Q1 | $1.06M | Sell |
9,826
-740
| -7% | -$79.2K | 0.05% | 193 |
|
|
2020
Q4 | $1.13M | Buy |
10,566
+269
| +3% | +$25.9K | 0.05% | 177 |
|
|
2020
Q3 | $902K | Sell |
10,297
-244
| -2% | -$23K | 0.04% | 189 |
|
|
2020
Q2 | $1.03M | Buy |
10,541
+2,838
| +37% | +$250K | 0.05% | 168 |
|
|
2020
Q1 | $587K | Buy |
7,703
+1,539
| +25% | +$131K | 0.04% | 210 |
|
|
2019
Q4 | $546K | Sell |
6,164
-5,011
| -45% | -$416K | 0.03% | 235 |
|
|
2019
Q3 | $846K | Buy |
11,175
+51
| +0.5% | +$3.5K | 0.05% | 174 |
|
|
2019
Q2 | $809K | Buy |
11,124
+40
| +0.4% | +$3.14K | 0.05% | 182 |
|
|
2019
Q1 | $893K | Sell |
11,084
-51
| -0.5% | -$4.17K | 0.05% | 172 |
|
|
2018
Q4 | $1.03M | Buy |
11,135
+296
| +3% | +$26K | 0.06% | 179 |
|
|
2018
Q3 | $1.02M | Buy |
10,839
+689
| +7% | +$65.3K | 0.06% | 169 |
|
|
2018
Q2 | $940K | Buy |
10,150
+675
| +7% | +$65.9K | 0.06% | 172 |
|
|
2018
Q1 | $897K | Sell |
9,475
-2,816
| -23% | -$309K | 0.05% | 169 |
|
|
2017
Q4 | $1.19M | Sell |
12,291
-416
| -3% | -$39.2K | 0.06% | 159 |
|
|
2017
Q3 | $1.13M | Sell |
12,707
-1,928
| -13% | -$147K | 0.06% | 143 |
|
|
2017
Q2 | $1.06M | Sell |
14,635
-806
| -5% | -$54.2K | 0.06% | 153 |
|
|
2017
Q1 | $1.01M | Sell |
15,441
-1,393
| -8% | -$87.6K | 0.06% | 143 |
|
|
2016
Q4 | $1.05M | Buy |
16,834
+3,772
| +29% | +$230K | 0.07% | 135 |
|
|
2016
Q3 | $824K | Buy |
13,062
+534
| +4% | +$34.6K | 0.06% | 149 |
|
|
2016
Q2 | $776K | Sell |
12,528
-3,741
| -23% | -$228K | 0.06% | 155 |
|
|
2016
Q1 | $929K | Buy |
16,269
+659
| +4% | +$36.7K | 0.07% | 127 |
|
|
2015
Q4 | $925K | Buy |
15,610
+488
| +3% | +$28.1K | 0.06% | 134 |
|
|
2015
Q3 | $823K | Sell |
15,122
-700
| -4% | -$45.6K | 0.07% | 123 |
|
|
2015
Q2 | $1.06M | Sell |
15,822
-136
| -0.9% | -$8.88K | 0.08% | 113 |
|
|
2015
Q1 | $934K | Buy |
15,958
+6,039
| +61% | +$365K | 0.08% | 108 |
|
|
2014
Q4 | $649K | Buy |
9,919
+3,510
| +55% | +$221K | 0.06% | 126 |
|
|
2014
Q3 | $370K | Buy |
6,409
+1,273
| +25% | +$70.7K | 0.04% | 159 |
|
|
2014
Q2 | $290K | Buy |
5,136
+6
| +0.1% | +$315 | 0.03% | 170 |
|
|
2014
Q1 | $264K | Sell |
5,130
-413
| -7% | -$20.9K | 0.03% | 155 |
|
|
2013
Q4 | $293K | Sell |
5,543
-8,810
| -61% | -$433K | 0.04% | 144 |
|
|
2013
Q3 | $642K | Buy |
14,353
+9,355
| +187% | +$415K | 0.1% | 77 |
|
|
2013
Q2 | $207K | Buy |
+4,998
| New | +$219K | 0.04% | 123 |
|
Other funds holding ABBV
VCM
VPM
First Foundation Advisors's ABBV Position: Q1 2026 in Review
First Foundation Advisors reduced its AbbVie (ABBV) stake by 3.2% in Q1 2026, selling an estimated $68.8K and leaving 9,520 shares worth $2.07M. The position accounts for 0.08% of the portfolio, ranked #140.
First Foundation Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.27M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First Foundation Advisors held 9,520 shares of AbbVie worth $2.07M as of Q1 2026.
- First Foundation Advisors sold 310 AbbVie shares in Q1 2026, an estimated $68.8K.
- AbbVie made up 0.08% of First Foundation Advisors's portfolio in Q1 2026, its #140 holding.
- First Foundation Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- First Foundation Advisors's AbbVie position peaked at $2.27M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.